Natural killer cell therapy potentially enhances the antitumor effects of bevacizumab plus irinotecan in a glioblastoma mouse model.
Tran TA, Kim YH, Duong TH, Thangaraj J, Chu TH, Jung S, Kim IY, Moon KS, Kim YJ, Lee TK, Lee CW, Yun H, Lee JJ, Lee HJ, Lee KH, Jung TY.
Tran TA, et al. Among authors: lee cw, lee tk, lee kh, lee jj, lee hj.
Front Immunol. 2023 Jan 10;13:1009484. doi: 10.3389/fimmu.2022.1009484. eCollection 2022.
Front Immunol. 2023.
PMID: 36703992
Free PMC article.